BALAXI PHARMACEUTICALS
Back to Income Statement
|
BALAXI PHARMACEUTICALS Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹-1.34 | ₹10.16 | ₹9.64 | ₹7.45 | ₹1.23 |
What is the latest Earnings Per Share (EPS) of BALAXI PHARMACEUTICALS ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹-1.34 |
| Mar2024 | ₹10.16 |
| Mar2023 | ₹9.64 |
| Mar2022 | ₹7.45 |
| Mar2021 | ₹1.23 |
How is Earnings Per Share (EPS) of BALAXI PHARMACEUTICALS Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1.34 | Negative | |
| Mar2024 | ₹10.16 | 5.39 | |
| Mar2023 | ₹9.64 | 29.40 | |
| Mar2022 | ₹7.45 | 505.69 | |
| Mar2021 | ₹1.23 | - | |
Compare Earnings Per Share (EPS) of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹126.2 Cr | -3.9% | -18.3% | -67.4% | Stock Analytics | |
| ADANI ENTERPRISES | ₹287,822.0 Cr | 11.6% | -2.1% | 1.7% | Stock Analytics | |
| REDINGTON | ₹20,994.6 Cr | -0% | -5.6% | 31.1% | Stock Analytics | |
| MMTC | ₹9,603.0 Cr | 2% | -5.9% | -6.6% | Stock Analytics | |
| HONASA CONSUMER | ₹9,279.6 Cr | 3.6% | -5% | 22.8% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹9,147.1 Cr | 4.2% | -10.5% | 25.7% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -3.9% |
-18.3% |
-67.4% |
| SENSEX | 3.5% |
-1.7% |
7.8% |
You may also like the below Video Courses